Received May 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | — | — |
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | UNK | — | — |
Patient received a dose of TDaP and hepatitis B (vaccine specifics not available at this time) approximately 3 weeks prior to symptom onset. About 2 weeks prior to symptom onset patient was ill with influenza A for approximately 3 days. Her symptoms included fevers, cough, body aches and fatigue. She recovered from influenza. Her GBS symptoms started 4/15/25 with neck and back pain. She then developed hand and feet numbness, tingling and pain. She was hospitalized from 4/17-4/19 and diagnosed with Guillain-Barre Syndrome, treated with IVIG and as of 4/28 is making a slow recovery.
none
irritable bowel syndrome
sertraline 50 MG daily
sulfa antibiotics